Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 4, 2006, Pages 251-257

  Sandoval, Helga P ^a   Fernández De Castro, Luis E ^a   Vroman, David T ^a   Solomon, Kerry D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACULAR LS; EYE DROPS; KETOROLAC TROMETAMOL; PHENYLEPHRINE; TROPICAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BURNING SENSATION; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INTRAOCULAR FOREIGN BODY; INTRAOCULAR PRESSURE; LENS IMPLANTATION; MALE; PHACOEMULSIFICATION; RANDOMIZED CONTROLLED TRIAL; SLIT LAMP; STATISTICAL ANALYSIS; VISUAL ACUITY; DRUG EFFECT; DRUG SCREENING; INFLAMMATION; IRIDOCYCLITIS; PATHOPHYSIOLOGY; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; DRUG EVALUATION; FEMALE; HUMANS; INFLAMMATION; INTRAOCULAR PRESSURE; KETOROLAC TROMETHAMINE; LENS IMPLANTATION, INTRAOCULAR; MALE; OPHTHALMIC SOLUTIONS; PATIENT SATISFACTION; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UVEITIS, ANTERIOR; VISUAL ACUITY;

EID: 33749131731     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.251     Document Type: Article

References (19)

1. DeAndrade, J.R., Maslanka, M., Maneatis, T., Bynum, L., and Buchmore, M. The use of ketorolac in the management of postoperative pain. Orthopedics 17:157-166, 1994.
2. Flach, A.J., Dolan, B.J., and Irvine, A.R. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am. J. Ophthalmol 103:479-486, 1987.
3. Solomon, K.D., Cheetham, J.K., DeGryse, R., et al. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 108:331-337, 2001.
4. Simone, J.N., Pendelton, R.A., and Jenkins, J.E. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. J. Cataract Refract. Surg. 25:699-704, 1999.
5. Flach, A.J., Graham, J., Kruger, L.P., et al. Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution. Arch. Ophthalmol. 106:344-347, 1988.
6. Flach, A.J., Lavelle, C.J., Olander, K.W., et al. The effect of ketorolac tromethamine 0.5% in reducing post-operative inflammation after cataract extraction and intraocular lens implantation. Ophthalmology 95:1279-1284, 1988.
7. Solomon, K.D., Vroman, D.T., Barker, D., et al. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective, randomized, double-masked study. J. Cataract Refract. Surg. 27:1232-1237, 2001.
8. Holzer, M.P., Solomon, K.D., Sandoval, H.P., et al. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for treatment of inflammation following phacoemulsification: A prospective, randomized, double-masked study. J. Cataract Refract. Surg. 28:93-99, 2002.
9. Yee, R.W. Analgesic efficacy and safety of nonpreserved ketorolac tromethamine ophthalmic solution following radial keratotomy. Ketorolac Radial Keratotomy Study Group. Am. J. Ophthalmol. 125:472-480, 1998.
10. McDonald, M.B., Brint, S.F., Caplan, D.I., et al. Comparison of ketorolac tromethamine, diclofenac sodium, and moist drops for ocular pain after radial keratotomy. J. Cataract Refract. Surg. 25:1097-1108, 1999.
11. Rajpal, R.K., and Cooperman, B.B. Analgesic efficacy and safety of ketorolac after photorefractive keratectomy. Ketorolac Study Group. J. Refract. Surg. 15:661-667, 1999.
12. Kosrirukvongs, P., Prabhasawat, P., Srivannaboon, S., et al. Topical ketorolac tromethamine in the reduction of adverse effects of laser in situ keratomileusis. J. Med. Assoc. [Thai.] 84:804-810, 2001.
13. Yaylali, V., Demirlenk, I., Tatlipinar, S., et al. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. Acta. Ophthalmol. [Scand.] 81:378-382, 2003.
14. Solomon, K.D., Vroman, D.T., Barker, D., et al. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective, randomized, double-masked study. J. Cataract Refract. Surg. 27:1232-1237, 2001.
15. Teal, P., Breslin, C., Arshinoff, S., et al. Corneal subepithelial infiltrates following excimer laser photorefractive keratectomy. J. Cataract Refract. Surg. 21:516-518, 1995.
16. Guidera, A.C., Luchs, J.I., and Udell, I.J. Keratitis, ulceration, and perforation associated with topical non-steroidal anti-inflammatory drugs. Ophthalmology 108:936-944, 2001.
17. Ladas, J.G., Wheeler, N.C., Morhun, P.J., et al. Laser flare-cell photometry methodology and clinical applications. Surv. Ophthalmol. 50:27-47, 2005.
18. Price, M.O., and Price, F.W. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery. Curr. Med. Res. Opin. 20:2015-2019, 2004.
19. Solomon, K.D., Donnenfeld, E.D., Raizman, M., et al. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in postphotorefractive keratectomy patients. J. Cataract Refract. Surg. 30:1653-1660, 2004.